William Grossman, Chief Officer of enGene Therapeutics ENGN, has filed 1 purchase and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $10.1K. The latest trade was on 09/22.

William Grossman

Interim Chief Medical Officer

Company

enGene Therapeutics ENGN

First filing

24/01/19

Trades

16 trades

Buys / sales

1 / 0

12-month net buying

$10.1K

Last trade

09/22

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
enGene TherapeuticsENGN	Open-market buy	09/22	09/24	5,102 sh	$1.97	$10,050.94	No record